共 158 条
[1]
Szarvas T(2011)Matrix metalloproteinases and their clinical relevance in urinary bladder cancer Nat Rev Urol. 8 241-254
[2]
vom Dorp F(2009)Targeting matrix metalloproteinases in inflammatory conditions Curr Drug Targets 10 1245-1254
[3]
Ergün S(2010)Matrix metalloproteinases involvement in pathologic conditions Rom J Morphol Embryol 51 215-228
[4]
Rübben H(2011)Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease Am J Nephrol 34 211-219
[5]
Clutterbuck AL(2014)Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors Biochem Pharmacol 90 7-15
[6]
Asplin KE(2007)Role of matrix metalloproteinases in renal pathophysiologies Am J Physiol Renal Physiol 292 F905-F911
[7]
Harris P(2012)Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target Basic Clin Pharmacol Toxicol 110 409-415
[8]
Allaway D(2009)Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease Circulation 120 792-801
[9]
Mobasheri A(2014)A current understanding of vascular calcification in CKD Am J Physiol Renal Physiol 307 F891-F900
[10]
Amălinei C(2002)Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 251-262